Compare Sana Biotechnology Inc (SANA) vs S&P500 ETF (SPY) Price & Performance

Sana Biotechnology IncTrade

S&P500 ETFTrade

Price performance (Past 24H)

Key statistics

Sana Biotechnology Inc vs S&P500 ETF — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while S&P500 ETF trades at $748.05. The key difference: S&P500 ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

	SANA	SPY
Market Cap	$873.84M	—
Sector	Health	—
52-Week High	$5.92	$759.55
52-Week Low	$2.68	$621.75
Enterprise Value	$848.03M	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SANA

View details →

SPY

Vanguard's VEA ETF offers low-cost developed market exposure beyond the U.S., balancing diversification and risk.24/7 Wall Street · 6 hours agoNeutral John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 13 hours agoBullish XLK ETF hides high concentration risk in top tech stocks despite low fees.24/7 Wall Street · 1 day agoNeutral View details →

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.